What is Drug Testing Network?
Drug Testing Network, Inc. operates as a premier authority in the development and management of drug-free workplace initiatives. The organization specializes in complex Department of Transportation (DOT) drug and alcohol testing protocols, alongside private and home-based diagnostic solutions. By mitigating liability and ensuring strict adherence to federal compliance standards, the company serves as a critical partner for enterprises navigating the intricacies of substance abuse policy. With leadership rooted in former Drug Enforcement Administration expertise, the firm combines deep regulatory knowledge with a commitment to operational integrity, positioning itself as a cornerstone of corporate risk management and workplace safety infrastructure.
How much funding has Drug Testing Network raised?
Drug Testing Network has raised a total of $31K across 1 funding round:
Debt
$31K
Debt (2021): $31K with participation from PPP
Key Investors in Drug Testing Network
PPP
Public-Private Partnership
What's next for Drug Testing Network?
With the infusion of this latest capital, Drug Testing Network is strategically positioned to scale its national and international service capabilities. The company is expected to prioritize the integration of advanced diagnostic technologies and the expansion of its compliance advisory services to meet the evolving demands of global supply chains and transportation logistics. As the regulatory landscape for workplace safety becomes increasingly stringent, the firm's focus on reducing non-compliance fines and liability exposure will likely drive further market penetration. Future growth initiatives will likely center on enhancing digital infrastructure to support real-time testing data management, ensuring that clients maintain seamless, audit-ready environments while navigating complex legal and safety frameworks.
See full Drug Testing Network company page
